These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5444338)

  • 1. An analogue of guinea pig C8: in vitro generation and inhibitory activity.
    Stolfi RL
    J Immunol; 1970 May; 104(5):1212-9. PubMed ID: 5444338
    [No Abstract]   [Full Text] [Related]  

  • 2. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    Tamura N; Nelson RA
    J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of guinea pig complement by aromaticamidine and guanidine compounds.
    Bing DH
    J Immunol; 1970 Nov; 105(5):1289-91. PubMed ID: 5489072
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the eighth component of complement (C8) by ethylenediaminetetra-acetate (EDTA).
    Schultz DR; Zarco RM
    J Immunol; 1970 Feb; 104(2):279-88. PubMed ID: 4983887
    [No Abstract]   [Full Text] [Related]  

  • 5. [C1-inactivator from guinea pig serum-mechanism of action. I. Effect of the inactivator on C1 in free solution].
    Loos M; Opferkuch W; Wagner H
    Z Med Mikrobiol Immunol; 1971; 156(2):208-20. PubMed ID: 4995250
    [No Abstract]   [Full Text] [Related]  

  • 6. An antigen density effect on the hemolytic efficiency of complement.
    Linscott WD
    J Immunol; 1970 May; 104(5):1307-9. PubMed ID: 4192162
    [No Abstract]   [Full Text] [Related]  

  • 7. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 8. The fifth component of the guinea pig complement system. 3. Dissociation and transfer of C5b, and the probable site of C5b fixation.
    Shin HS; Pickering RJ; Mayer MM
    J Immunol; 1971 Feb; 106(2):480-93. PubMed ID: 5545154
    [No Abstract]   [Full Text] [Related]  

  • 9. [The C1-inactivator of guinea pig serum: titration, purification and characterization of the inactivator].
    Opferkuch W; Loos M; Ringelmann R
    Z Med Mikrobiol Immunol; 1971; 156(2):194-207. PubMed ID: 4995249
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
    Lang JM; Hainaut J
    Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of guinea pig complement by maleopimaric acid and other derivatives of levopimaric acid.
    Glovsky MM; Becker EL; Halbrook NJ
    J Immunol; 1968 May; 100(5):979-90. PubMed ID: 5648478
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
    McLeod B; Baker P; Gewurz H
    Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory activity of ninhydrin on the hemolytic activity of guinea pig complement].
    Schena L; Piacentini I; Bonomi U
    Fracastoro; 1971; 64(4):236-41. PubMed ID: 5003309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the temperature-dependant denaturation of guinea pig complement].
    Sugama T
    Nihon Hoigaku Zasshi; 1966 Sep; 20(5):488-95. PubMed ID: 6010573
    [No Abstract]   [Full Text] [Related]  

  • 16. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the C3b inactivator or conglutinogen activating factor (KAF).
    Lachmann PJ; Nicol P; Aston WP
    Immunochemistry; 1973 Oct; 10(10):695-700. PubMed ID: 4202955
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparation of the 3d component of guinea pig cmplement (C3)].
    Takahashi S; Okada H; Nishioka K
    Arerugi; 1970 Dec; 19(12):859-67. PubMed ID: 5531032
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement associated peptidase activity of guinea pig serum. I. Role of complement components.
    Cooper NR; Becker EL
    J Immunol; 1967 Jan; 98(1):119-31. PubMed ID: 6018765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.